Author:
Cocconi Giorgio,Bisagni Giancarlo,Ceci Guido,Blasio Beatrice Di,Lisi Vincenzo De,Passalacqua Rodolfo,Zadro Alvise,Boni Corrado,Morandi Paolo,Savoldi Luisa
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Wittes RE, Adrianza ME, Parsons B, Felix J, Marsoni S: Compilation of phase II results with single antineoplastic agents. Cancer Treat Symposia 4: 1–477, 1985
2. Kolaric K, Roth A: Phase II clinical trial of cisdichlorodiammine platinum (Cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer. Cancer Chemother Pharmacol 11: 108–112, 1983
3. Sledge GW Jr., Loehrer PJ Sr., Roth BJ, Einhom LH: Cisplatin as first-line therapy for metastatic breast cancer. J Clin Oncol 6: 1811–1814, 1988
4. Peters WP, Jones RB, Vredenburgh J, Shpall EJ, Hussein A, Elkordy M, Rubin P, Ross M, Berry D: A large prospective, randomized trial of high-dose combination alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM). 'Abstract'. Proceed ASCO 15: 149, 1996
5. Cocconi G, Bisagni G, Bacchi M, Boni C, Bartolucci R, Ceci G, Colozza MA, De Lisi V, Lottici R, Mosconi AM, Passalacqua R, Tonato M: Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research. J Clin Oncol 9: 664–669, 1991
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献